Regencell Bioscience Holdings Limited carries a market capitalization of 5.26B, placing it among publicly traded companies globally.
| Market Cap | 5.26B |
| Enterprise Value | N/A |
Regencell Bioscience Holdings Limited's stock has declined approximately -33.8116% over the past 52 weeks. The 50-day moving average sits at 6.42, while the 200-day moving average is 18.39.
| Beta (5Y) | N/A |
| 52-Week Price Change | -33.8116% |
| 50-Day Moving Average | 6.42 |
| 200-Day Moving Average | 18.39 |
| Average Volume (20 Days) | N/A |
Regencell Bioscience Holdings Limited's most recent stock split took place on June 16, 2025 with a 1:38 split ratio.
| Last Split Date | 6/16/2025 |
| Split Ratio | 1:38 |
Already premium?